Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Net Income (2021 - 2025)

Historic Net Income for MDxHealth (MDXH) over the last 5 years, with Q3 2025 value amounting to -$8.0 million.

  • MDxHealth's Net Income rose 2368.0% to -$8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$31.1 million, marking a year-over-year increase of 2470.19%. This contributed to the annual value of -$38.1 million for FY2024, which is 1167.29% up from last year.
  • Latest data reveals that MDxHealth reported Net Income of -$8.0 million as of Q3 2025, which was up 2368.0% from -$7.4 million recorded in Q2 2025.
  • In the past 5 years, MDxHealth's Net Income registered a high of -$6.7 million during Q4 2024, and its lowest value of -$18.1 billion during Q2 2022.
  • Moreover, its 5-year median value for Net Income was -$10.0 million (2023), whereas its average is -$1.1 billion.
  • Its Net Income has fluctuated over the past 5 years, first crashed by 9366.22% in 2022, then skyrocketed by 9994.13% in 2023.
  • Quarter analysis of 5 years shows MDxHealth's Net Income stood at -$8.1 million in 2021, then tumbled by 50.73% to -$12.2 million in 2022, then rose by 12.02% to -$10.7 million in 2023, then surged by 37.07% to -$6.7 million in 2024, then decreased by 18.93% to -$8.0 million in 2025.
  • Its Net Income stands at -$8.0 million for Q3 2025, versus -$7.4 million for Q2 2025 and -$8.9 million for Q1 2025.